Next-Generation Neuromodulation System for Personalized Treatment Planning and Real-Time Optimization

Publication ID: 24-11857249_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Neuromodulation System for Personalized Treatment Planning and Real-Time Optimization,” Published Technical Disclosure No. 24-11857249_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857249_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,249.

Summary of the Inventive Concept

A novel neuromodulation system that leverages machine learning, real-time impedance analysis, and patient-specific data to predict optimal energy delivery parameters and enable personalized treatment planning and real-time optimization.

Background and Problem Solved

The original patent addressed the need for monitoring and controlling deployment of a neuromodulation element within a body lumen. However, it had limitations in terms of predicting optimal energy delivery parameters and adjusting to changes in vessel geometry. The new inventive concept addresses these limitations by incorporating machine learning and real-time impedance analysis to enable personalized treatment planning and real-time optimization.

Detailed Description of the Inventive Concept

The new inventive concept consists of a neural interface device configured to monitor and control deployment of a neuromodulation element within a body lumen. The system further comprises a machine learning module to predict optimal energy delivery parameters based on real-time impedance analysis and patient-specific data. The system can analyze impedance data from a treatment site to identify optimal electrode placement and energy delivery parameters, and generate a personalized treatment plan based on the analysis. The system can also adjust energy delivery in real-time based on changes in impedance at the treatment site.

Novelty and Inventive Step

The new inventive concept is novel and non-obvious in its use of machine learning and real-time impedance analysis to predict optimal energy delivery parameters and enable personalized treatment planning and real-time optimization. The original patent did not contemplate the use of machine learning or real-time impedance analysis, and the new claims provide a significant advancement in the field of neuromodulation.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, different types of sensors to detect changes in vessel geometry, or different cloud-based data analytics platforms to enable real-time monitoring and optimization of treatment outcomes.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in the field of neuromodulation, particularly in the treatment of chronic pain, hypertension, and other conditions. The system's ability to enable personalized treatment planning and real-time optimization could lead to improved treatment outcomes and increased adoption in the medical industry.

CPC Classifications

SectionClassGroup
A A61 A61B18/1492
A A61 A61N1/36057
A A61 A61N1/36139
A A61 A61B2018/00267
A A61 A61B2018/00404
A A61 A61B2018/00434
A A61 A61B2018/00511
A A61 A61B2018/00577
A A61 A61B2018/00875
A A61 A61B2018/00898
A A61 A61B2018/144
A A61 A61B2018/1475
A A61 A61N1/0551

Original Patent Information

Patent NumberUS 11,857,249
TitleDevices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology
Assignee(s)Medtronic Ireland Manufacturing Unlimited Company